Patents by Inventor Gholam Hossein Hakimelahi

Gholam Hossein Hakimelahi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8372849
    Abstract: This invention relates to heterocyclic compounds of the formulas shown in the specification. It also relates to methods for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, and tissue injuries with one of the heterocyclic compounds.
    Type: Grant
    Filed: November 3, 2008
    Date of Patent: February 12, 2013
    Assignee: Taigen Biotechnology Co., Ltd.
    Inventors: Chi-Feng Yen, Cheng-Kung Hu, Chang-Pin Huang, Ying-Huey Huang, Gholam Hossein Hakimelahi, Chi-Hsin Richard King
  • Publication number: 20090264339
    Abstract: This invention relates to heterocyclic compounds of the formulas shown in the specification. It also relates to methods for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, and tissue injuries with one of the heterocyclic compounds.
    Type: Application
    Filed: November 3, 2008
    Publication date: October 22, 2009
    Applicant: TaiGen Biotechnology Co., Ltd.
    Inventors: Chi-Feng Yen, Cheng-Kung Hu, Chang-Pin Huang, Ying-Huey Huang, Gholam Hossein Hakimelahi, Chi-Hsin Richard King
  • Patent number: 7504422
    Abstract: This invention relates to methods for treating retinopathy and repairing tissue damage. The methods include administering to a subject in need thereof an effective amount of one or more compounds of the following formula. Each variable in this formula is defined in the specification.
    Type: Grant
    Filed: August 6, 2007
    Date of Patent: March 17, 2009
    Assignee: Taigen Biotechnology Co. Ltd.
    Inventors: Chi-Feng Yen, Chi-Hsin Richard King, Hua-Chien Chen, Gholam Hossein Hakimelahi, Shu-Jen Chen, Ying-Huey Huang, Chien-Huang Wu
  • Patent number: 7501526
    Abstract: This invention relates to methods of preparing the compounds of formula (V): Each variable in this formula is defined in the specification.
    Type: Grant
    Filed: January 20, 2005
    Date of Patent: March 10, 2009
    Assignee: Taigen Biotechnology
    Inventors: Chien-Huang Wu, Jia-Liang Zhu, Chen-Tso Tseng, Chi-Feng Yen, Kak-Shan Shia, Yibin Xiang, Gholam Hossein Hakimelahi, Ming-Chen Chou
  • Patent number: 7399776
    Abstract: This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject in need thereof an effective amount of one or more compounds of the following formula. Each variable in this formula is defined in the specification.
    Type: Grant
    Filed: March 30, 2004
    Date of Patent: July 15, 2008
    Assignee: Taigen Biotechnology
    Inventors: Kak-Shan Shia, Gholam Hossein Hakimelahi, Jia-Liang Zhu, Chi-Feng Yen, Ying-Huey Huang, Yibin Xiang, Hua-Chien Chen, Ching-Cheng Wang
  • Patent number: 6825348
    Abstract: This invention relates to purine compounds of formula (I): R1 is NH2 or OH; R2 is H or NH2; R3 is H or alkyl; each of m and n, independently, is 1, 2, 3, or 4; X is O, S, or NH; and Y is H, halogen, ORa, P(O)(ORa)2, or P(O)(ORa)(ORb), in which Ra is H, alkyl, aryl, heteroaryl, cyclyl, heterocyclyl, and Rb is wherein A is adenine, guanine, cytosine, uracil, or thymine; Rc is H or OH; Rd is H or alkyl; Re is H, alkyl, or 5-ethylidene-(3,4-dialkoxyl)-furan-2-one; provided that if R1 is NH2, R2 is H; and if R1 is OH, R2 is NH2.
    Type: Grant
    Filed: June 25, 2002
    Date of Patent: November 30, 2004
    Assignee: Academia Sinica
    Inventor: Gholam Hossein Hakimelahi
  • Publication number: 20040002475
    Abstract: This invention relates to purine compounds of formula (I): 1
    Type: Application
    Filed: June 25, 2002
    Publication date: January 1, 2004
    Inventor: Gholam Hossein Hakimelahi